Results 321 to 330 of about 198,722 (342)
Some of the next articles are maybe not open access.
BRAF Inhibitors
2013 Stephan Mose, Stephan Mose, Brandon J. Fisher, Iris Rusu, Charlie Ma, Lu Wang, Larry C. Daugherty, Brandon J. Fisher, Stephan Mose, Tod W. Speer, Tod W. Speer, Anthony E. Dragun, Rene Rubin, Claudia Rübe, James H. Brashears, Stephan Mose, James H. Brashears, Christian Weiss, Claus Roedel, Christian Weiss, Claus Roedel, Edward J. Gracely, Rene Rubin, Lindsay G. Jensen, Brent S. Rose, Loren K. Mell, Arno J. Mundt, Iris Rusu, Anthony E. Dragun, Anthony E. Dragun, Albert S. DeNittis, Christin A. Knowlton, Michelle Kolton Mackay, Yan Yu, Laura Doyle, Cheng B. Saw, Yan Yu, Laura Doyle, Ning J. Yue, Rene Rubin, Nisha R. Patel, Michael L. Wong, Brian F. Hasson, Daniel Yeung, Jatinder Palta, Christin A. Knowlton, Michelle Kolton Mackay, James H. Brashears, Anthony E. Dragun, Anthony E. Dragun, David E. Wazer, Anthony E. Dragun, Anthony E. Dragun, Stephan Mose, Susan M. Varnum, Marianne B. Sowa, William F. Morgan +56 moreopenaire +1 more sourceDabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
The Lancet, 2015 G. Long, D. Stroyakovskiy, H. Gogas, E. Levchenko, F. de Braud, J. Larkin, C. Garbe, T. Jouary, A. Hauschild, J. Grob, V. Chiarion-Sileni, C. Lebbé, M. Mandalà, M. Millward, A. Arance, I. Bondarenko, J. Haanen, J. Hansson, J. Utikal, V. Ferraresi, N. Kovalenko, P. Mohr, Volodymr Probachai, D. Schadendorf, P. Nathan, C. Robert, A. Ribas, D. Demarini, J. Irani, S. Swann, J. Legos, F. Jin, B. Mookerjee, K. Flaherty +33 moresemanticscholar +1 more source
